Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients

The aim of this study was to investigate the pharmacokinetics and safety of voriconazole after intravenous (i.v.) administration in immunocompromised children (2 to 11 years old) and adults (20 to 60 years old) who required treatment for the prevention or therapy of systemic fungal infections. Nine...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Michael, Claudia, Bierbach, Uta, Frenzel, Katrin, Lange, Thoralf, Basara, Nadezda, Niederwieser, Dietger, Mauz-Körholz, Christine, Preiss, Rainer
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2010
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916341/
https://ncbi.nlm.nih.gov/pubmed/20547816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01731-09
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki